Home Trials Genes Drugs 23andMe Graph Blog Contact

Home
Trials
Genes
Drugs
23andMe
Graph
Blog
Contact

Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

ClinicalTrials.gov
OpenTargets
ClinVar
PubChem

Results for “Erythroblastosis Fetalis, Rh Disease”

5 trials

Filters

Phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Status

Recruiting

Active, Not Recruiting

Not Yet Recruiting

Completed

Enrolling by Invitation

Showing 5 of 5 results

Large-scale testing (Phase 3)UnknownNCT03104426

What this trial is testing

Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Pregnant Women at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn (HDFN)

Who this might be right for

Hemolytic Disease of the Fetus and Newborn

Janssen Research & Development, LLC 25

Large-scale testing (Phase 3)Study completedNCT00295516

What this trial is testing

Doppler or Amniocentesis to Predict Fetal Anemia

Who this might be right for

Rh Isoimmunization

University of Toronto 157

Filters

Phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Status

Recruiting

Active, Not Recruiting

Not Yet Recruiting

Completed

Enrolling by Invitation

Results for “Erythroblastosis Fetalis, Rh Disease”

EPO-4-Rhesus Study

Delayed Cord Clamping in Rhesus Disease of the Newborn

The Prevention of Rh Disease of Newborns in Pakistan

Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Pregnant Women at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn (HDFN)

Doppler or Amniocentesis to Predict Fetal Anemia